Godfrey Kigozi1, Richard Musoke2, Nehemiah Kighoma2, Noah Kiwanuka3, Fred Makumbi4, Fred Nalugoda2, Fred Wabwire-Mangen3, David Serwadda4, Maria Joan Wawer5, Ronald Henry Gray5. 1. Rakai Health Sciences Program, Entebbe, Uganda. Electronic address: gkigozi@rhsp.org. 2. Rakai Health Sciences Program, Entebbe, Uganda. 3. Department of Epidemiology and Biostatistics, the School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda. 4. Rakai Health Sciences Program, Entebbe, Uganda; Department of Epidemiology and Biostatistics, the School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda. 5. Rakai Health Sciences Program, Entebbe, Uganda; Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD.
Abstract
OBJECTIVE: To assess the safety of medical male circumcision (MMC) among human immunodeficiency virus (HIV)-infected men with CD4 levels <350 cells/mm(3), CD4 counts ≥ 350 cells/mm(3), and HIV-negative men. METHODS: Two hundred forty-two HIV-infected men and a sample of 262 HIV-negative consenting men aged 12 years or older who requested free MMC were enrolled in a prospective study. Blood for HIV testing and a CD4 count were collected before surgery. During weekly follow-up over 6 weeks, data were collected on wound healing and adverse events (AEs) by examination, and resumption of sex and condom use ascertained by interview. Surgery-related AEs were characterized by type, severity, management, and resolution. Chi-square and Fisher's exact tests were used to test for differences in AE proportions. RESULTS: Overall, only 2 of the 453 men experienced moderate AEs, a rate of 0.44 per 100 surgeries. No AE occurred among HIV-negative men, whereas the AE rate among HIV-infected men with CD4 counts ≥ 350 cells/mm(3) was 0.79 per 100 surgeries, and among men with CD4 counts <350 cells/mm(3) the rate was 1.19 per 100 surgeries (P = .214). AE rates were comparable for all characteristics (P >.05). CONCLUSION: HIV-positive men can be safely included in MMC roll out programs without necessitating presurgery CD4 counts determination.
OBJECTIVE: To assess the safety of medical male circumcision (MMC) among human immunodeficiency virus (HIV)-infectedmen with CD4 levels <350 cells/mm(3), CD4 counts ≥ 350 cells/mm(3), and HIV-negative men. METHODS: Two hundred forty-two HIV-infectedmen and a sample of 262 HIV-negative consenting men aged 12 years or older who requested free MMC were enrolled in a prospective study. Blood for HIV testing and a CD4 count were collected before surgery. During weekly follow-up over 6 weeks, data were collected on wound healing and adverse events (AEs) by examination, and resumption of sex and condom use ascertained by interview. Surgery-related AEs were characterized by type, severity, management, and resolution. Chi-square and Fisher's exact tests were used to test for differences in AE proportions. RESULTS: Overall, only 2 of the 453 men experienced moderate AEs, a rate of 0.44 per 100 surgeries. No AE occurred among HIV-negative men, whereas the AE rate among HIV-infectedmen with CD4 counts ≥ 350 cells/mm(3) was 0.79 per 100 surgeries, and among men with CD4 counts <350 cells/mm(3) the rate was 1.19 per 100 surgeries (P = .214). AE rates were comparable for all characteristics (P >.05). CONCLUSION:HIV-positive men can be safely included in MMC roll out programs without necessitating presurgery CD4 counts determination.
Authors: Javier R Lama; Shelly T Karuna; Shannon P Grant; Edith M Swann; Carmela Ganoza; Patricia Segura; Silvia M Montano; Martin Lacherre; Stephen C De Rosa; Susan Buchbinder; Jorge Sanchez; M Juliana McElrath; Maria P Lemos Journal: PLoS One Date: 2016-08-18 Impact factor: 3.240
Authors: Edward I Broughton; Esther Karamagi; Angella Kigonya; Anna Lawino; Lani Marquez; Sarah Smith Lunsford; Albert Twinomugisha Journal: PLoS One Date: 2018-04-19 Impact factor: 3.240
Authors: Mutaawe Lubogo; Ronald Anguzu; Humphrey Wanzira; Abdul R Shour; Aggrey D Mukose; Agnes Nyabigambo; Nazarius M Tumwesigye Journal: Afr Health Sci Date: 2019-09 Impact factor: 0.927
Authors: Caryl Feldacker; Isaac Holeman; Vernon Murenje; Sinokuthemba Xaba; Michael Korir; Bill Wambua; Batsirai Makunike-Chikwinya; Marrianne Holec; Scott Barnhart; Mufuta Tshimanga Journal: PLoS One Date: 2020-06-16 Impact factor: 3.240